跳至主要内容
临床试验/EUCTR2009-014292-52-GB
EUCTR2009-014292-52-GB进行中(未招募)1 期

Tacrolimus vs prednisolone for the treatment of nephrotic syndrome secondary to minimal change disease: A Randomised Control Trial - Tacrolimus vs prednisolone for minimal change disease

Imperial College NHS trust0 个研究点目标入组 52 人开始时间: 2010年8月4日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients presenting to participating hospital renal clinics with nephrotic syndrome (hypoalbuminaemia and protein creatinine ratio(PCR) >100units), secondary to minimal change disease.
  • Age over 18.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Hepatitis B, hepatitis C or HIV infection
  • 2.Untreated infection
  • 3.Females who are pregnant, breast feeding, or at risk of pregnancy and not using a medically acceptable form of contraception.
  • 4. Patients who have been treated with immunosuppression over the last 18 months.
  • 5. Patients who have had more than 3 relapses of nephrotic syndrome within 5 years
  • 6. Any condition judged by the investigator that would cause the study to be detrimental to the patient

研究者

发起方
Imperial College NHS trust

相似试验